- Home
- COLL vs TIPT Comparison
COLL vs TIPT Comparison
Compare COLL & TIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- TIPT
- Stock Information
- Founded
- COLL 2002
- TIPT 2007
- Country
- COLL United States
- TIPT United States
- Employees
- COLL N/A
- TIPT N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- TIPT Property-Casualty Insurers
- Sector
- COLL Health Care
- TIPT Finance
- Exchange
- COLL Nasdaq
- TIPT Nasdaq
- Market Cap
- COLL 958.8M
- TIPT 856.4M
- IPO Year
- COLL 2015
- TIPT 2007
- Fundamental
- Price
- COLL $31.60
- TIPT $21.19
- Analyst Decision
- COLL Strong Buy
- TIPT
- Analyst Count
- COLL 4
- TIPT 0
- Target Price
- COLL $43.75
- TIPT N/A
- AVG Volume (30 Days)
- COLL 291.1K
- TIPT 227.4K
- Earning Date
- COLL 08-07-2025
- TIPT 07-30-2025
- Dividend Yield
- COLL N/A
- TIPT 1.13%
- EPS Growth
- COLL N/A
- TIPT 107.58
- EPS
- COLL 1.25
- TIPT 1.20
- Revenue
- COLL $664,283,000.00
- TIPT $2,042,059,000.00
- Revenue This Year
- COLL $20.23
- TIPT N/A
- Revenue Next Year
- COLL $3.82
- TIPT N/A
- P/E Ratio
- COLL $25.23
- TIPT $17.54
- Revenue Growth
- COLL 17.17
- TIPT 15.66
- 52 Week Low
- COLL $23.23
- TIPT $17.07
- 52 Week High
- COLL $42.29
- TIPT $26.90
- Technical
- Relative Strength Index (RSI)
- COLL 61.58
- TIPT 42.92
- Support Level
- COLL $31.53
- TIPT $20.35
- Resistance Level
- COLL $32.95
- TIPT $21.61
- Average True Range (ATR)
- COLL 0.88
- TIPT 0.92
- MACD
- COLL 0.06
- TIPT -0.21
- Stochastic Oscillator
- COLL 73.51
- TIPT 19.09
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About TIPT Tiptree Inc.
Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.